Literature DB >> 12974769

Memory B lymphocytes determine repertoire oligoclonality early after haematopoietic stem cell transplantation.

B Omazic1, I Lundkvist, J Mattsson, J Permert, I Nasman-Bjork.   

Abstract

The objective of this study was to investigate if oligoclonality of the Ig repertoire post-haematopoietic stem cell transplantation (HSCT) is restricted to memory B lymphocytes or if it is a general property among B lymphocytes. As a measure of B lymphocyte repertoire diversity, we have analysed size distribution of polymerase chain reaction (PCR) amplified Ig H complementarity determining region 3 (CDR3) in naive and memory B lymphocytes isolated from patients before HSCT and at 3, 6 and 12 months after HSCT as well as from healthy controls. We demonstrate a limited variation of the IgH CDR3 repertoire in the memory B lymphocyte population compared to the naive B cell population. This difference was significant at 3 and 6 months post-HSCT. Compared to healthy controls there is a significant restriction of the memory B lymphocyte repertoire at 3 months after HSCT, but not of the naive B lymphocyte repertoire. Twelve months after HSCT, the IgH CDR3 repertoire in both memory and naive B lymphocytes are as diverse as in healthy controls. Thus, our findings suggest a role for memory B cells in the restriction of the oligoclonal B cell repertoire observed early after HSCT, which may be of importance when considering reimmunization of transplanted patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12974769      PMCID: PMC1808844          DOI: 10.1046/j.1365-2249.2003.02260.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  CD27: a memory B-cell marker.

Authors:  K Agematsu; S Hokibara; H Nagumo; A Komiyama
Journal:  Immunol Today       Date:  2000-05

Review 2.  Reconstitution of the B cell repertoire after bone marrow transplantation does not recapitulate human fetal development.

Authors:  F M Raaphorst
Journal:  Bone Marrow Transplant       Date:  1999-12       Impact factor: 5.483

3.  Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantation.

Authors:  J Storek; G Espino; M A Dawson; B Storer; M E Flowers; D G Maloney
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

4.  B-cell-autonomous somatic mutation deficit following bone marrow transplant.

Authors:  A M Glas; E H van Montfort; J Storek; E G Green; R P Drissen; V J Bechtold; J Z Reilly; M A Dawson; E C Milner
Journal:  Blood       Date:  2000-08-01       Impact factor: 22.113

5.  Immunoglobulin G subclass deficiency and pneumococcal infection after allogeneic bone marrow transplantation.

Authors:  J F Sheridan; P J Tutschka; D D Sedmak; E A Copelan
Journal:  Blood       Date:  1990-04-01       Impact factor: 22.113

6.  Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia.

Authors:  H Zetterquist; J Mattsson; M Uzunel; I Näsman-Björk; P Svenberg; L Tammik; G Bayat; J Winiarski; O Ringdén
Journal:  Bone Marrow Transplant       Date:  2000-04       Impact factor: 5.483

7.  Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease.

Authors:  J Mattsson; M Uzunel; M Remberger; P Ljungman; E Kimby; O Ringdén; H Zetterquist
Journal:  Leukemia       Date:  2000-02       Impact factor: 11.528

8.  Long-term persistence of oligoclonal serum IgM repertoires in patients treated with allogeneic bone marrow transplantation (BMT).

Authors:  I N Björk; C Brissac; M Remberger; J Mattsson; S Klaesson; O Ringdén; J Stewart; I Lundkvist
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

9.  Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation.

Authors:  M Remberger; B M Svahn; P Hentschke; C Löfgren; O Ringdén
Journal:  Bone Marrow Transplant       Date:  1999-10       Impact factor: 5.483

10.  Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.

Authors:  R Storb; H J Deeg; J Whitehead; F Appelbaum; P Beatty; W Bensinger; C D Buckner; R Clift; K Doney; V Farewell
Journal:  N Engl J Med       Date:  1986-03-20       Impact factor: 91.245

View more
  6 in total

Review 1.  Translational Mini-Review Series on B cell subsets in disease. Reconstitution after haematopoietic stem cell transplantation - revelation of B cell developmental pathways and lineage phenotypes.

Authors:  M Bemark; J Holmqvist; J Abrahamsson; K Mellgren
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

Review 2.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.

Authors:  Juan Gea-Banacloche; Krishna V Komanduri; Paul Carpenter; Sophie Paczesny; Stefanie Sarantopoulos; Jo-Anne Young; Nahed El Kassar; Robert Q Le; Kirk R Schultz; Linda M Griffith; Bipin N Savani; John R Wingard
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-14       Impact factor: 5.742

Review 3.  Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation.

Authors:  Kirsten M Williams; Ronald E Gress
Journal:  Best Pract Res Clin Haematol       Date:  2008-09       Impact factor: 3.020

Review 4.  Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Justyna Ogonek; Mateja Kralj Juric; Sakhila Ghimire; Pavankumar Reddy Varanasi; Ernst Holler; Hildegard Greinix; Eva Weissinger
Journal:  Front Immunol       Date:  2016-11-17       Impact factor: 7.561

Review 5.  Mass Cytometry for the Assessment of Immune Reconstitution After Hematopoietic Stem Cell Transplantation.

Authors:  Lauren Stern; Helen McGuire; Selmir Avdic; Simone Rizzetto; Barbara Fazekas de St Groth; Fabio Luciani; Barry Slobedman; Emily Blyth
Journal:  Front Immunol       Date:  2018-07-26       Impact factor: 7.561

Review 6.  T cell regeneration after immunological injury.

Authors:  Enrico Velardi; Jennifer J Tsai; Marcel R M van den Brink
Journal:  Nat Rev Immunol       Date:  2020-10-23       Impact factor: 53.106

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.